Quadrant Capital Group’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $303K | Buy |
16,660
+629
| +4% | +$11.5K | 0.01% | 1133 |
|
|
2025
Q1 | $318K | Buy |
16,031
+15,429
| +2,563% | +$306K | 0.01% | 1048 |
|
|
2024
Q4 | $10.3K | Sell |
602
-390
| -39% | -$6.69K | ﹤0.01% | 2118 |
|
|
2024
Q3 | $19.8K | Buy |
+992
| New | +$19.8K | ﹤0.01% | 1892 |
|
|
2023
Q4 | – | Sell |
-867
| Closed | -$3.1K | – | 2693 |
|
|
2023
Q3 | $3.1K | Hold |
867
| – | – | ﹤0.01% | 2284 |
|
|
2023
Q2 | $3.2K | Hold |
867
| – | – | ﹤0.01% | 2307 |
|
|
2023
Q1 | $2.87K | Buy |
+867
| New | +$2.87K | ﹤0.01% | 2357 |
|